United States · Platforms & data · MarketBeat
FY2029 EPS Forecast for Kura Oncology Decreased by Analyst

Detailed summary
Kura Oncology, Inc. (NASDAQ:KURA - Free Report) - Equities research analysts at Brookline Capital Markets dropped their FY2029 earnings per share estimates for Kura Oncology in a research report issued on Tuesday, November 10th. Brookline Capital Markets analyst L. Cann now anticipates that the comp
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)




